Similar articles

• Inflammatory bowel disease: lessons from animal models.

  Lauer K. Lauer K. Am J Gastroenterol. 2008 Mar;103(3):802. doi: 10.1111/j.1572-0241.2007.01612_5.x. Am J Gastroenterol. 2008. PMID: 18341503 No abstract available.
• Inflammatory bowel disease: maladaptation of the vigilant genotype in a hyper-clean world?

  Rajan TV. Rajan TV. Perspect Biol Med. 2006 Spring;49(2):171-7. doi: 10.1353/pbm.2006.0029. Perspect Biol Med. 2006. PMID: 16702702
• Role of the innate immune system in the pathogenesis of inflammatory bowel disease.

  van Lierop PP, Samsom JN, Escher JC, Nieuwenhuis EE. van Lierop PP, et al. J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):142-51. doi: 10.1097/MPG.0b013e3181821964. J Pediatr Gastroenterol Nutr. 2009. PMID: 19179875 Review.
• Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease.

  Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, Raedler A. Schreiber S, et al. Gastroenterology. 1995 Jan;108(1):21-33. doi: 10.1016/0016-5085(95)90004-7. Gastroenterology. 1995. PMID: 7806044
• Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms.

  De Schepper HU, De Man JG, Moreels TG, Pelckmans PA, De Winter BY. De Schepper HU, et al. Aliment Pharmacol Ther. 2008 Apr;27(8):621-37. doi: 10.1111/j.1365-2036.2008.03624.x. Epub 2008 Jan 23. Aliment Pharmacol Ther. 2008. PMID: 18221407 Review.